Eli Lilly and Company (NYSE:LLY – Get Free Report) was the target of some unusual options trading on Thursday. Traders acquired 138,522 call options on the company. This represents an increase of 87% compared to the typical volume of 74,172 call options. Eli Lilly and Company Stock Up 0.8% NYSE:L... Read more
Watch List News - Nov 13
Eli Lilly and Company (NYSE:LLY – Get Free Report) saw unusually large options trading on Thursday. Investors acquired 138,522 call options on the company. This represents an increase of approximately 87% compared to the typical daily volume of 74,172 call options. Institutional Trading of Eli Li... Read more
Ticker Report - Nov 13
49 Wealth Management LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 16.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 423 shares of the company’s stock after selling 84 shares during the period. 49 Wealth Management LLC’s holdi... Read more
Americanbankingnews - Nov 10
Glucagon-like Peptide 1 (GLP-1) Analogues Market reached US$ 62.81 Billion in 2024 and is expected to reach US$ 299.08 Billion by 2033, growing at a CAGR of 17.6 % during the forecast period 2025-2033.DataM Intelligence has released its latest report Read more
Openpr.com - Nov 10
The Central Nervous System Disorders Therapeutics market is estimated to be valued at USD 97,028.1 Mn in 2025 and is expected to reach USD 159,583.2 Mn by 2032, growing at a compound annual growth rate CAGR of 7.4% from 2025 Read more
Openpr.com - Nov 05
The Asia Pacific Generic Oncology Sterile Injectable market is estimated to be valued at USD 1,303.8 Mn in 2025 and is expected to reach USD 8,832.6 Mn by 2032, growing at a compound annual growth rate CAGR of 12.2% from Read more
Openpr.com - Nov 04
